WeVote
Log In

Bill

Bill

A 253

Requires quarterly reporting on the amounts awarded and received from the opioid stewardship fund

2025 Regular Session Introduced by Judy Griffin and 5 co-sponsors

Requires quarterly public reports on amounts awarded from and received into the opioid stewardship fund, boosting transparency for agencies, recipients, and taxpayers.

REPORTED REFERRED TO WAYS AND MEANS
0
WeVote Research Nonpartisan
Bill Summary · A 253

Summary of Assembly Bill A 253

Overview

A 253 is an Assembly bill introduced on January 8, 2025, titled: “Requires quarterly reporting on the amounts awarded and received from the opioid stewardship fund.” The bill is currently in the fiscal review track, having been reported from committee and referred to Ways and Means for consideration.

Purpose and intent

  • To increase transparency and accountability regarding the opioid stewardship fund.
  • To require regular, quarterly disclosure of how funds from the opioid stewardship fund are awarded (disbursed) and how the fund receives money (inflows).

Key provisions (as indicated by the bill title and status)

  • Quarterly reporting requirement on:
    • Amounts awarded from the opioid stewardship fund (disbursements to programs, services, or recipients).
    • Amounts received into the opioid stewardship fund (inflows, such as appropriations, revenues, or transfers).
  • The reported data would likely cover timeframes within each quarter and include pertinent details (e.g., recipients, purposes, and totals), with specifics to be defined in the final text.
  • The provision aims to ensure ongoing, public-facing accountability for how the fund is used and how funds come into and exit the fund.

Note: The exact elements required in the quarterly reports (e.g., level of detail, reporting format, who compiles the report) would be defined in the bill’s final text and any implementing regulations.

Who is affected

  • State agencies and offices administering or managing the opioid stewardship fund, and any programs or sub-recipients receiving fund awards.
  • Potentially the executive and legislative branches through transparency and oversight obligations.
  • The general public and taxpayers, via public quarterly reporting on fund activity.

Procedural and timeline aspects

  • Introduced: January 8, 2025.
  • Initial committee action: Referred to Alcoholism and Drug Abuse (January 8, 2025).
  • Subsequent action: Reported and referred to Ways and Means (February 11, 2025) for fiscal analysis and potential budgetary impact review.
  • Related actions listed twice in the record, reflecting standard committee reporting and cross-referral processes.
  • Related bills:
    • Companion in Senate: S 670
    • Prior-session related: A 9100

Sponsors

  • Primary sponsor: Phil Steck
  • Cosponsors: Judy Griffin, Tommy Schiavoni, Carrie Woerner, Albert A. Stirpe, Paula Kay

Potential impact and considerations

  • Pros: Improves transparency of fund usage; enhances oversight and public trust; helps track efficiency and effectiveness of opioid-related programs.
  • Cons/considerations: May require additional administrative effort and reporting infrastructure; fiscal notes may be generated by Ways and Means to assess budgetary impact.
  • Next steps: If advanced by Ways and Means, the bill could move toward floor consideration and potential final passage, followed by a Senate companion (S 670) for alignment.

This summary reflects the information available in the bill’s current record and related actions.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.